Influenza A Virus Matrix Protein 1 anticorps
Aperçu rapide pour Influenza A Virus Matrix Protein 1 anticorps (ABIN7478355)
Antigène
Voir toutes Influenza A Virus Matrix Protein 1 (M1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- Purified matrix protein (M1)
-
Réactivité croisée (Details)
- Does not react with HEp-2 cells by indirect immunofluorescence. Does not react with the M2 matrix protein
-
Purification
- This product consists of the purified IgG fraction of the above antiserum.
-
Pureté
- > 95 %
-
Immunogène
- Influenza A, Phillipines (H3N2)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- TITER : >1:160 by indirect immunofluorescence, Potential applications for this product are numerous including ELISA, fluorescence microscopy, immunoblotting and immunohistochemistry. In addition, this product may be used in place of neat antiserum in almost any appropriate antibody-based technique. It is also suitable for conjugation purposes.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- The product is formulated in a phosphate saline buffer (0.01M, pH 7.2) containing 0.1 % sodium azide preservative. No stabilizing proteins have been added.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Recommended short term (<6 months) storage is liquid at 2-8°C. For longer term storage, aliquot and freeze.
-
-
- Influenza A Virus Matrix Protein 1 (M1)
-
Autre désignation
- Influenza A Matrix Protein M1
Antigène
-